483 Document: Azurity Pharmaceuticals, Inc., Feb 24, 2022

FDANews 483 Azurity Pharmaceuticals, Inc. Feb 24 2022 top
Erik W. Koester FDA Investigator Terry Bridgewater FDA Investigator

On Feb 24, 2022, the FDA inspected Azurity Pharmaceuticals, Inc.'s Wilmington site. Explore the inspectional observations.